Site Search
Professionals 19 results
Capabilities 10 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Experience 1 result
Experience
|September 1, 2019
Winston Secures Favorable Settlement for Virtualization Company in 10-Patent Case
Represented VMware in two litigations brought by Intellectual Ventures and related proceedings before the U.S. Patent Trial & Appeal Board. The cases involved ten patents allegedly directed towards cloud computing, networking and virtualization techniques. The cases were very significant, involving hundreds of VMware product offerings. The cases were pending before Judge Albright in the U.S. District Court for the Western District of Texas. The litigations settled after claim construction proceedings and after Winston filed multiple IPR challenges.
Insights & News 101 results
In the Media
|April 6, 2026
|1 Min Read
Alexander Ott Joins Winston in Washington, D.C.
Winston & Strawn recently announced that Alexander Ott has joined the firm’s Washington, D.C. office as a partner in the Litigation Department and a member of the International Trade Commission (ITC) Practice. Alex focuses on complex patent disputes and represents clients in high-technology industries, including semiconductor, wireless networking, LED, and software technologies. He has led numerous ITC Section 337 investigations and has represented clients before the Federal Circuit, in inter partes review (IPR) and post-grant review proceedings at the U.S. Patent and Trademark Office (USPTO), and in federal district courts.
Press Release
|April 1, 2026
|1 Min Read
Winston Expands IP Practice with ITC Partner Alexander Ott
Washington, D.C. – April 1, 2026 – Winston & Strawn LLP announced today that Alexander Ott has joined the firm as a partner in the Litigation Department and the International Trade Commission (ITC) Practice in Washington, D.C.
In the Media
|March 25, 2026
|1 Min Read
Brett Johnson Discusses Federal Circuit’s PTAB Review Decisions with Law360
Winston & Strawn partner Brett Johnson was quoted in a Law360 article examining the U.S. Court of Appeals for the Federal Circuit’s recent decisions declining to review the U.S. Patent and Trademark Office director’s discretionary denials of inter partes review (IPR) and post-grant review (PGR) petitions. Companies have filed constitutional arguments at the Federal Circuit challenging the high and evolving threshold for having an inter partes or post-grant review instituted, which has led to an unprecedented level of denied petitions. The companies had hoped to fit into a narrow exception to the America Invents Act that allows appeals for unconstitutional “shenanigans,” but the Federal Circuit has rejected all of the mandamus petitions since November.
Other Results 12 results
Law Glossary
What Is an Inter Partes Review (IPR)?
An inter partes review of a patent is a type of administrative trial proceeding. Inter partes review became available in 2012 and replaced inter partes reexamination as a way to challenge patentability at the Patent Office. Any person who is not the owner of a patent can file a petition for a review of a patent. The Patent Trial and Appeal Board (PTAB) will act on the petition either instituting a trial or denying institution of a trial. This will occur a little over six months after the petition is filed. If trial is instituted, the proceeding will, with some limited exceptions, be resolved within one year.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.